BAMF
UTHR icon

BI Asset Management Fondsmaeglerselskab’s United Therapeutics UTHR Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.83M Buy
12,597
+5,968
+90% +$3.36M 0.05% 252
2026
Q1 		$3.93M Sell
6,629
-5,246
-44% -$2.61M 0.04% 273
2025
Q4 		$5.79M Sell
11,875
-17,188
-59% -$8M 0.05% 238
2025
Q3 		$12.2M Sell
29,063
-11,537
-28% -$3.88M 0.11% 150
2025
Q2 		$11.7M Sell
40,600
-43,266
-52% -$12.9M 0.11% 157
2025
Q1 		$25.9M Sell
83,866
-1,376
-2% -$472K 0.29% 77
2024
Q4 		$30.1M Buy
85,242
+14,964
+21% +$5.5M 0.32% 66
2024
Q3 		$25.2M Sell
70,278
-5,391
-7% -$1.82M 0.44% 53
2024
Q2 		$24.1M Buy
75,669
+51,096
+208% +$13.5M 0.39% 66
2024
Q1 		$5.64M Buy
24,573
+6,708
+38% +$1.51M 0.11% 155
2023
Q4 		$3.93M Buy
17,865
+13,988
+361% +$3.22M 0.08% 189
2023
Q3 		$876K Buy
3,877
+2,955
+320% +$681K 0.02% 399
2023
Q2 		$204K Sell
922
-2,380
-72% -$527K ﹤0.01% 612
2023
Q1 		$740K Buy
3,302
+2,216
+204% +$546K 0.02% 389
2022
Q4 		$302K Buy
+1,086
New +$274K 0.01% 478
2022
Q3 		– Sell
-884
Closed -$208K – 491
2022
Q2 		$208K Buy
+884
New +$180K 0.01% 398
2019
Q2 		– Sell
-1,000
Closed -$117K – 315
2019
Q1 		$117K Sell
1,000
-1,300
-57% -$151K 0.01% 196
2018
Q4 		$250K Buy
+2,300
New +$267K 0.02% 180

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

BI Asset Management Fondsmaeglerselskab's UTHR Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its United Therapeutics (UTHR) stake by 90% in Q2 2026, buying an estimated $3.36M and bringing the position to 12,597 shares worth $6.83M. The position accounts for 0.05% of the portfolio, ranked #252.

BI Asset Management Fondsmaeglerselskab first reported a position in UTHR in Q4 2018 and has held it in 18 quarters since. The position peaked at $30.1M in Q4 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 12,597 shares of United Therapeutics worth $6.83M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 5,968 United Therapeutics shares in Q2 2026, an estimated $3.36M.
  • United Therapeutics made up 0.05% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #252 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in United Therapeutics in Q4 2018 and has held it in 18 quarters since.
  • BI Asset Management Fondsmaeglerselskab's United Therapeutics position peaked at $30.1M in Q4 2024.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.